Intrusive thoughts. Compulsions that offer only momentary relief. If OCD hasn't fully responded to medication or therapy, transcranial magnetic stimulation is an emerging option worth understanding — including exactly what is, and isn't, established for it.
Maybe you've been through exposure and response prevention therapy. Maybe you've tried an SSRI, or two, at the higher doses OCD often requires. And maybe, despite all of that, the intrusive thoughts and the rituals that follow them haven't fully let go. That's a real and common experience — OCD is one of the more treatment-resistant conditions in psychiatry, and it's reasonable to be looking at what else exists.
In 2018, the FDA cleared a form of deep transcranial magnetic stimulation for OCD — the first noninvasive device clearance for the condition. That clearance is specific: it applies to a deep TMS system using a specialized coil (the H7 coil, and later an equivalent coil from a different manufacturer) that targets the medial prefrontal cortex and anterior cingulate cortex, brain regions tied to OCD's specific circuitry.
Exomind's standard protocol — the one used for depression, anxiety, brain fog, and food noise — targets a different region, the dorsolateral prefrontal cortex, using a different coil. That protocol is not the FDA-cleared configuration for OCD.
Honest framing: Exomind is not FDA-cleared to treat OCD. Any use of Exomind for OCD-related symptoms would be a supportive, investigational application of the technology — not the specific, cleared deep-TMS protocol described above. We believe you deserve to know that distinction clearly before deciding whether to pursue anything here.
Every consultation starts with an honest conversation about your history — prior therapy, prior medication trials, and what your OCD actually looks like day to day. Dr. Eric Evans, MD, our Medical Director and a board-certified anesthesiologist with 30+ years of clinical experience, will tell you plainly whether Exomind's current protocol is a reasonable option to discuss for you, or whether you'd be better served by a specialized deep-TMS OCD program, continued ERP therapy, or a medication adjustment with your psychiatrist.
If we do move forward, Exomind is positioned as a complement to your existing OCD care — not a replacement for ERP therapy or medication managed by your prescribing provider.
If your OCD is severe, a program using the specific FDA-cleared deep-TMS protocol may be the more appropriate first option — we'll tell you that honestly if it's the case.
We don't have Exomind-specific outcome data for OCD to share with you, and we won't imply otherwise. Because Exomind's standard protocol is not the FDA-cleared configuration for OCD, we are not in a position to give you reliable outcome expectations here. This is exactly the kind of question your consultation with Dr. Evans is meant to answer honestly.
The most common side effects of TMS generally are mild scalp discomfort or headache during or shortly after a session. Seizure is a rare but serious risk associated with TMS, which is why every patient is screened for contraindications beforehand.
No. The FDA clearance for TMS-and-OCD applies to a specific deep-TMS device and coil configuration that targets a different brain region than Exomind's standard protocol. We want that distinction to be completely clear before you make any decision.
Possibly — and we'll tell you honestly if that seems like the better fit during your consultation. Our role is to give you an accurate picture of your options, not to steer you toward what we happen to offer.
No. Any changes to your OCD medication or therapy should be made with your prescribing provider or therapist. Exomind, if pursued, is intended as a complement to that care.
It begins with a free consultation — a conversation, not a commitment. Dr. Evans will give you a straightforward assessment of whether it's worth pursuing.
Your free consultation includes a candid discussion of what's established, what's investigational, and what may be the better path for your OCD.
Request Your Free ConsultationCall (435) 522-5190This page is for educational purposes and is not medical advice. Exomind is FDA-cleared for the treatment of major depressive disorder; it is not FDA-cleared for OCD. The FDA clearance for TMS-and-OCD applies to a specific deep-TMS device and coil configuration targeting the medial prefrontal cortex and anterior cingulate cortex, which differs from Exomind's standard dorsolateral-prefrontal-cortex protocol. Any use of Exomind for OCD-related symptoms is a supportive, investigational application, is not intended to diagnose, treat, cure, or prevent any disease, and is not a substitute for evidence-based OCD treatment such as exposure and response prevention therapy or medication managed by a licensed provider. Outcome data cited from published research reflects a different device and protocol than Exomind's standard configuration and is not a claim about Exomind's own results. Reading this page or submitting a form does not create a provider-patient relationship. If you are experiencing a mental-health emergency, call 911 or call/text 988.